CCL21 Cancer Immunotherapy

@inproceedings{Lin2014CCL21CI,
  title={CCL21 Cancer Immunotherapy},
  author={Yuan Lin and Sherven P Sharma and Maie St. John},
  booktitle={Cancers},
  year={2014}
}
Cancer, a major health problem, affects 12 million people worldwide every year. With surgery and chemo-radiation the long term survival rate for the majority of cancer patients is dismal. Thus novel treatments are urgently needed. Immunotherapy, the harnessing of the immune system to destroy cancer cells is an attractive option with potential for long term anti-tumor benefit. Cytokines are biological response modifiers that stimulate anti-tumor immune responses. In this review, we discuss the… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 59 REFERENCES

A cytokine delivering polymer is effective in reducing tumor burden in an HNSCC murine model. Otolaryngol

  • Y. Lin, J. Luo, +7 authors M. A. St. John
  • Head Neck Surg
  • 2014
3 Excerpts

Current status and future perspectives of dendritic cell-based cancer immunotherapy

  • D. H. Yi, S. Appel
  • Scand. J. Immunol
  • 2013
2 Excerpts

Similar Papers

Loading similar papers…